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Abstract
Inflammation is known to be responsible for the sensitization of peripheral sensory neurons, leading to spontaneous pain
and invalidating pain hypersensitivity. Given its role in regulating neuronal excitability, the voltage-gated Nav1.9 channel is
a potential target for the treatment of pathological pain, but its implication in inflammatory pain is yet not fully described.
In the present study, we examined the role of the Nav1.9 channel in acute, subacute and chronic inflammatory pain using
Nav1.9-null mice and Nav1.9 knock-down rats. In mice we found that, although the Nav1.9 channel does not contribute to
basal pain thresholds, it plays an important role in heat pain hypersensitivity induced by subacute paw inflammation
(intraplantar carrageenan) and chronic ankle inflammation (complete Freund’s adjuvant-induced monoarthritis). We showed
for the first time that Nav1.9 also contributes to mechanical hypersensitivity in both models, as assessed using von Frey and
dynamic weight bearing tests. Consistently, antisense-based Nav1.9 gene silencing in rats reduced carrageenan-induced
heat and mechanical pain hypersensitivity. While no changes in Nav1.9 mRNA levels were detected in dorsal root ganglia
(DRGs) during subacute and chronic inflammation, a significant increase in Nav1.9 immunoreactivity was observed in
ipsilateral DRGs 24 hours following carrageenan injection. This was correlated with an increase in Nav1.9 immunolabeling in
nerve fibers surrounding the inflamed area. No change in Nav1.9 current density could be detected in the soma of
retrolabeled DRG neurons innervating inflamed tissues, suggesting that newly produced channels may be non-functional at
this level and rather contribute to the observed increase in axonal transport. Our results provide evidence that Nav1.9 plays
a crucial role in the generation of heat and mechanical pain hypersensitivity, both in subacute and chronic inflammatory
pain models, and bring new elements for the understanding of its regulation in those models.
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Introduction
Acute or chronic pathological tissue inflammation strongly
impacts on pain perception by sensitizing peripheral sensory
neurons, giving rise to local and incapacitating pain hypersensitivity.
Inflammatory mediators are known to enhance nociceptive primary
afferent fibers excitability, in part by modifying expression and/or
function of ionic channels present in nerve endings [1]. Voltage-
gated sodium channels (VGSCs) play a fundamental role in
neuronal excitability as they are directly responsible for initiation
and propagation of action potentials, and their implication in
different chronic pain disorders, including inflammatory pain, is
relatively well established [2]. Among the 10 VGSC isoforms, two
tetrodotoxin-resistant (TTX-R) channels, Nav1.8 and Nav1.9, are
almost exclusively expressed in nociceptors, consistently with a
specific involvement in nociceptive pathways [3,4,5,6]. Nav1.8 has
been shown to generate a slowly-inactivating sodium current with a
relatively depolarized activation threshold, underlying the depolar-
izing phase of action potential in C-type fibers [7,8,9]. Several
knock-down and knock-out studies have clearly demonstrated its
contribution to pain hypersensitivity in both neuropathic and
inflammatory models [10,11,12,13,14]. More recently, a link
between Nav1.9 channel and inflammatory pain hypersensitivity
has also been established [15,16].
Nav1.9 channel shows atypical properties. Its voltage-dependent
activation is shifted to hyperpolarized potentials compared to
Nav1.8 and TTX-sensitive channels [17], and its activation and
inactivation curves are widely overlapping around the resting
potential, enabling it to produce a persistent sodium current
component [18,19]. Moreover, its slow activation kinetics argues
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23083
against a contribution of Nav1.9 to the depolarizing phase of the
action potential [18,9]. Therefore, it has been initially proposed
that Nav1.9 channel could rather contribute to the setting of the
excitability of nociceptive sensory neurons by modulating both
resting potential and response to subthreshold stimuli [20]. More
recently, it has been shown that inflammatory soup-triggered up-
regulation of Nav1.9 current increased the excitability of DRG
neurons by generating long-lasting plateau depolarization and
burst firing [21]. Other studies performed using different
inflammatory protagonists such as prostaglandin E2, protein
kinase C or G-proteins, also highlighted the link between
inflammatory pathways and Nav1.9-mediated increase in the
excitability of nociceptors [22,23,24,25].
This is consistent with the first behavioral observations made on
Nav1.9-null mice [15,16]. Knock-out mice did not show any
modification of their normal pain thresholds while both heat and
pressure hypersensitivities in response to intraplantar injections of
inflammatory mediators (prostaglandin E2, bradykinin or inter-
leukin-1b) were reduced. However, results obtained with inflam-
matory models remain to be completed and clarified as strong
discrepancies exist. Indeed, deletion of Nav1.9 was shown to either
diminish [15,16] or have no effect [26] on thermal pain
hypersensitivity produced by carrageenan or complete Freund
adjuvant (CFA) injections, and the reduction of mechanical
hypersensitivity observed in Nav1.92/2 mice in response to
inflammatory mediators was not confirmed in the CFA-induced
paw inflammation model [15,16,26] that is the only one tested
until now. Furthermore, whether Nav1.9 expression is modified
during inflammation is also still unclear, as conflicting results have
been published in different models, or at different time-points
following inflammation, showing either increased [5,16,27] or
stable [28,29] Nav1.9 expression.
As to settle those issues, we first performed a time-course study
of Nav1.9 involvement in thermal and mechanical pain hyper-
sensitivity, using both subacute and chronic (monoarthritis)
inflammatory pain models in Nav1.9 knock-out mice. Mechanical
pain was not only assessed by von Frey or paw pressure tests, but
also using a newly developed weight bearing test in freely moving
animals. To reinforce the robustness of the behavioral results
obtained with Nav1.9 knock-out mice, we performed a knock-
down study in inflamed rats. Behavioral data were then correlated
with molecular and electrophysiological analysis of Nav1.9
regulation in the same inflammatory pain models to allow an
overall comprehension of the role played by this channel in pain
hypersensitivity along the time-course of inflammation.
We first confirmed that healthy Nav1.9-null mice have no
modified heat and pressure pain thresholds. Then we showed that
the channel is involved in both heat and mechanical pain
hypersensitivity during subacute inflammation, and in the early
phase of monoarthritis development. Similar observations were
performed in the subacute inflammatory model using knock-down
strategy in rats. Behavioral results were not correlated with
changes in the channel transcription, but rather with variations of
protein levels in DRG cell bodies and with an increase in Nav1.9
transport to the nerve endings surrounding the site of inflamma-
tion. No modulation of Nav1.9 current was detected in the soma of
neurons innervating the inflamed zone, suggesting that the newly
produced channels are non-functional at the cell body level.
Results
Reduction of acute inflammatory pain in Nav1.92/2 mice
Formalin test was performed to assess acute inflammatory pain
in this Nav1.92/2 mouse strain (Fig. 1). Following intraplantar
formalin injection, mice painful behavior, characterized by the
licking or biting of the injected paw, was monitored during the two
typical phases of the test (0 to 5 min and 10 to 45 min). During the
first and non-inflammatory phase, Nav1.92/2 mice and wild-type
(WT) littermates exhibited similar spontaneous pain-related
behavior. In contrast, we observed a strong diminution in the
paw licking time in Nav1.9 knock-out mice during the second and
inflammatory phase of the test, which confirms the role played by
Nav1.9 in acute inflammatory pain [15].
Involvement of Nav1.9 in heat and mechanical pain
hypersensitivity induced by subacute inflammation
We evaluated the contribution of Nav1.9 channels to mechan-
ical and heat pain hypersensitivity in the carrageenan subacute
paw inflammation model. Mice were subjected to different
thermal and mechanical pain tests over a 24 h period following
intraplantar carrageenan. The intensity of the inflammatory
reaction was evaluated in Nav1.92/2 and WT mouse strains by
measuring the induced edema. No difference in paw swelling was
observed between strains (see supplementary Fig. S1A). Heat pain
threshold was evaluated by paw withdrawal latency after
immersion in a 46uC water bath (Fig. 2A). Basal responses to
noxious heat were identical between the two mouse strains, but
following intraplantar carrageenan WT mice developed a strong
hypersensitive phenotype (p#0.003 from 2 to 24 h) that was
significantly reduced in Nav1.92/2 mice at all times post-injection.
Similarly, carrageenan injection induced a subacute mechanical
hypersensitivity in WT mice (p#0.003 from 2 to 24 h) which was
significantly reduced in Nav1.92/2 mice 6 and 8 h post-injection
(Fig. 2B). To confirm the lower hypersensitivity in Nav1.9 knock-
out mice, we performed a dynamic evaluation of the weight
bearing of animals on their 4 limbs over a 5 min period. Eight
hours following carrageenan injection, a slight increase in contra/
ipsilateral weight ratio (Fig. 2C), as well as a strong increase in
inflamed hindpaw lifting time (Fig. 2D), were observed in WT
mice (p = 0.014 and p,0.001, respectively). The weight applied on
the forepaws was not affected (Fig. 2E–F). In Nav1.9 knock-out
mice, no such weight imbalance or postural alteration was
detected (p= 0.247 for contra/ipsilateral weight ratio, p = 0.883
for paw lifting time) and a significant difference between the two
strains was also found 8 h post-injection. Taken together, these
data demonstrate the involvement of Nav1.9 in mechanical pain
hypersensitivity in a subacute model of paw inflammation.
Compensatory mechanisms may occur in knock-out strains,
leading to changes in the expression of non-targeted genes, as
Figure 1. Nav1.9 knock-out mice behavioral response to
intraplantar formalin injection. Following intraplantar formalin,
the time spent licking/biting the injected paw is monitored during
45 min in Nav1.9+/+ (n = 9) and Nav1.92/2 (n = 8) mice. Data were
summed for the two typical phases of the test. Phase I: 0 to 5 min.
Phase II: 10 to 45 min. ##p,0.01 vs ‘+/+’, Student’s unpaired t-test.
doi:10.1371/journal.pone.0023083.g001
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previously shown in Nav1.82/2 mice in which an increase in
TTX-sensitive current density has been observed [11]. To prevent
any misinterpretation of the results obtained with Nav1.92/2
mice, we assessed behavioral reactions to noxious stimuli in
Nav1.9 knock-down rats following carrageenan paw inflammation.
This consisted in intrathecal injections of antisense oligodeoxynu-
cleotides (ODN) complementary to Nav1.9 transcript twice a day
during 3 days. Nav1.9 down-regulation by antisense ODN,
together with the lack of effect of a mismatch ODN or saline
injection, were validated in L5 DRGs by immunohistochemistry
(Fig. 3A–C). Following Nav1.9 antisense treatment, no difference
was found in heat and mechanical pain thresholds (Fig. 3D–E).
Paw inflammation was then induced by intraplantar carrageenan
injection. This lowered heat and mechanical pain thresholds of
rats, but the observed hypersensitivity was significantly reduced in
the Nav1.9-antisense treated group for both tests. These data
confirm the involvement of Nav1.9 channel in inflammatory pain
hypersensitivity, whatever the sensory modality tested.
We then performed a time course study of Nav1.9 transcript
and protein expression in L4 to L6 DRGs by quantitative RT-
PCR and immunohistochemistry, respectively. No variation in
Nav1.9 transcript level was found at any time post-carrageenan
(Fig. 4A). IL-6 transcript was assessed as a positive control, and a
two fold increase was detected in ipsilateral DRGs 2 h following
carrageenan injection (Fig. 4B). A slight decrease (around 15%) of
Nav1.9 immunolabeling was observed 8 h after carrageenan
injection in ipsilateral neurons compared to contralateral ones
(Fig. 5A–B,E). Such a decrease is significant in every tested animal
and was not observed in saline injected animals at the same time
point (data not shown). 24 h after injection, Nav1.9 immunolabel-
ing was increased in ipsilateral DRG neurons compared to
contralateral ones (Fig. 5C–D,F). Increase in Nav1.9 immunola-
beling was already detectable 16 h post-injection (data not shown).
We then assessed the size of Nav1.9-positive neurons since some
pathological processes have already been reported to induce
Nav1.9 expression in larger DRG neurons [30]. The distribution
of Nav1.9 labeling intensity plotted against the size of neurons did
not show any difference at any time point tested between contra
and ipsilateral DRG, as illustrated in Fig. 5G–H. To test whether
the transient decrease in Nav1.9 protein level in DRG neuron
somata resulted in an increase in Nav1.9 transport to peripheral
nerve endings, we searched for an accumulation of Nav1.9 protein
in inflamed territories. As it is nearly impossible to have an
exhaustive quantification of Nav1.9 protein level in sensory
endings within the epidermis, we rather looked at small nerve
trunks in the vicinity of the epidermis. Such trunks correspond to
very distal part of the sensory fibers and were identified by the
peripherin marker (Fig. 6B,E). Twenty-four hours after carra-
geenan injection, a marked accumulation of Nav1.9 protein was
observed in nerve trunks surrounding the inflamed skin (Fig. 6).
Finally, we investigated whether Nav1.9 current was potentiated
in the carrageenan subacute inflammation model. To this aim,
24 h following intraplantar carrageenan injection we performed
whole-cell patch clamp recordings from cultured small DRG
neurons (2462 pF, n= 21) that were innervating the inflamed
zone, as seen by retrograde labeling with the fluorescent dye DiI
that was previously injected intraplantarly. Nav1.9 current is
typically recorded at a test potential of 260 mV using fluoride in
the pipette solution [18,19]. Under these experimental conditions,
little if any Nav1.9 channel activity could be detectable
immediately after achieving the whole cell configuration. The
Nav1.9 current developed as fluoride diffuses into the cell. In
carrageenan condition, no Nav1.9 current was detectable at
260 mV, 1 min after the rupture of the membrane. However, as
fluoride diffuses, Nav1.9 currents could be recorded within
minutes (time to peak: 9.861.2 min, n = 12, Fig. 7A). This up-
regulation of Nav1.9 by fluoride was thereafter compared to the
control condition (i.e. saline injected-mice). As in the carrageenan
condition, Nav1.9 current was first not detectable at 260 mV,
1 min after achieving the whole cell configuration, but was up-
regulated by internal fluoride within minutes (time to peak:
8.961.0 min, n = 9, Fig. 7B). Neither the current amplitude
measured at 260 mV (228.164.8 pA/pF, n= 9 vs
229.264.3 pA/pF, n= 12) nor the current activation threshold
(271.761.5 mV, n= 9 vs 274.260.8 mV, n= 12) were signifi-
cantly different between saline and carrageenan conditions,
respectively, suggesting that the observed increase in Nav1.9
expression in cell bodies 24 h following carrageenan injection
involves non-functional channels.
Involvement of Nav1.9 in chronic inflammatory pain in
monoarthritic mice
To assess whether Nav1.9 channel also contributes to chronic
inflammatory pain, we performed a time-course study of Nav1.92/2
and WT mice pain thresholds following monoarthritis induction by
two peri-articular CFA injections on either side of the left ankle.
Figure 2. Nav1.9 knock-out mice pain sensitivity and weight
imbalance following carrageenan intraplantar injection. Fol-
lowing intraplantar carrageenan, heat and mechanical pain sensitivity of
Nav1.9+/+ and Nav1.92/2 mice was assessed over 24 h using 46uC paw
immersion test (A, n = 9), von Frey test (B, n = 9), and dynamic weight
bearing test (C–F, n = 5). The ipsi/contralateral hindpaw weight ratio is
shown in C and the ipsilateral paw lifting time in D. The mean weights
applied on ipsilateral and contralateral forepaws are also shown in E
and F, respectively. *p,0.05, **p,0.01, ***p,0.001 vs ‘+/+’, two way
ANOVA followed by Student-Newman-Keuls all pairwise multiple
comparison test.
doi:10.1371/journal.pone.0023083.g002
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Ankle swelling did not differ between the two mouse strains (see
supplementary Fig. S1B). As for the intraplantar carrageenan model,
heat pain threshold was evaluated by paw immersion test in a 46uC
water bath, up to the ankle. This model resulted in a strong
hypersensitivity to heat, characterized by the reduction of paw
withdrawal latencies from day 3 to day 21 in WT animals (p#0.007,
Fig. 8A). A significant reduction in heat hypersensitivity was
observed in Nav1.92/2 mice compared to the WT strain from
day 3 to day 7, similarly to what we obtained in WTmice treated by
daily intraperitoneal indomethacin injections (data not shown).
Mechanical pain, traduced by ankle incapacitance, was also
evaluated using the dynamic weight bearing. In WT mice, we
observed a strong increase in contra/ipsilateral weight ratio
(p,0.001 at day 7 only, Fig. 8B) as well as in inflamed hindpaw
lifting time (p,0.001 from day 3 to 14, non-significant at day 21,
Fig. 8C), with an acme 7 days following monoarthritis induction.
Anteroposterior weight balance was also affected as a strong increase
in ipsilateral (p#0.007 from day 3 to 21, Fig. 8D) and to a less extent
contralateral (p#0.050 at days 3, 10, 14 and 21, Fig. 8E) forepaws
weight could be detected, with a peak at day 7 and day 14,
respectively. All these observations were also made on Nav1.9 knock-
out mice, but a significant reduction in the phenotype intensity was
observed at day 7 for the ipsi/contralateral weight ratio, the inflamed
paw lifting time and the ipsilateral forepaw weight, and at day 14
concerning the contralateral forepaw. Taken together, these data
show that Nav1.9 channels contribute to heat as well as mechanical
arthritic pain.
In this model, quantitative RT-PCR on L4 to L6 DRGs did not
show any variation in Nav1.9 transcript level from day 0 to day 21
(Fig. 9A) whereas IL-6 transcript, used as a positive control, was
significantly increased from day 3 to 21 (Fig. 9B). Seven and ten
days following monoarthritis induction, no significant change in
Nav1.9 immunolabeling was detected in ipsilateral DRG neurons
compared to contralateral neurons (data not shown).
We finally investigated whether Nav1.9 channel activity was
modulated in the monoarthritic chronic inflammation model. We
performed the same experiments as with the carrageenan model,
i.e. whole-cell patch clamp recordings from cultured small DRG
neurons (2362 pF, n= 19) removed from animals 7 days following
monoarthritis induction. Only cells stained by retrograde labeling
with the fluorescent dye DiI (injected around the tibio-tarsal joint)
were considered. In monoarthritis condition, no Nav1.9 current is
detectable, at 260 mV, 1 min after the rupture of the membrane.
After several minutes (time to peak: 11.660.8 min, n= 11),
Nav1.9 current was up-regulated by internal fluoride (Fig. 10A)
with a mean current amplitude measured at 260 mV of
240.166.9 pA/pF (n = 11) and a current activation threshold of
Figure 3. Rats pain sensitivity following Nav1.9 antisense treatment and intraplantar carrageenan injection. Nav1.9 immunolabeling
on L5 DRGs from rats treated intrathecally with saline (A), mismatch ODN (B) and antisense ODN (C) for 3 days. Heat (D) and mechanical (E) pain
thresholds of rats (n = 8) are evaluated by 46uC paw immersion and paw pressure tests, respectively, before and 4 h after carrageenan intraplantar
injection. Pain thresholds are given as percentage from pre-ODN baseline. **p,0.01, ***p,0.001 vs ‘Post-ODN’ ; #p,0.05, ##p,0.01,
###p,0.001 vs ‘Antisense’, two way ANOVA followed by Student-Newman-Keuls all pairwise multiple comparison test. Scale bar 20 mm.
doi:10.1371/journal.pone.0023083.g003
Figure 4. Nav1.9 and IL-6 mRNA expression in mouse lumbar
DRGs following intraplantar carrageenan. Quantitative PCR
performed on Nav1.9 (A) and IL-6 (B) transcripts in L4 to L6 ipsilateral
DRGs of mice following intraplantar carrageenan (n = 3). Results are
given normalized to HPRT transcript levels. *p,0.05 vs ‘0’, one-way
ANOVA followed by Bonferroni multiple comparisons versus control
group.
doi:10.1371/journal.pone.0023083.g004
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275.460.8 mV (n= 11). In control condition, Nav1.9 current was
also undetectable, at 260 mV, 1 min after achieving the whole
cell configuration (Fig. 10B) and then reached a maximum
amplitude at 260 mV of 232.565.7 pA/pF (n = 8) within
12.260.7 min (n = 8). Nav1.9 activation threshold was
273.760.8 mV (n= 8) in control condition, which was undistin-
guishable from the activation threshold measured in the mono-
arthritis condition.
Discussion
In the present study, we investigated whether Nav1.9 channel
contributes to acute, subacute and chronic inflammatory pain in
mice and rats using knock-out and knock-down strategies,
respectively. We showed that whereas Nav1.9 is not involved in
basal pain thresholds, it plays an important role in acute
inflammatory pain, as well as in both mechanical and heat pain
Figure 5. Modulation of Nav1.9 protein level in sensory neuron cell body during carrageenan induced inflammation. Nav1.9
immunolabeling of ipsilateral and contralateral DRG sections from animals, 8 h (A–B) and 24 h (C–D) following injection of 3% carrageenan. Mean
fluorescence intensities of ipsilateral and contralateral neurons from 3 different animals are shown in E and F, 8 h and 24 h post-injection, respectively
(exact numbers of neurons quantified is indicated in each bar). To better compare fluorescence intensities, mean grey values were normalized setting
contralateral neuron populations to 100 AU. Mean grey value and diameter of Nav1.9-labeled neurons were measured in ipsilateral (green squares)
and contralateral (black circles) DRGs and plotted into graphs (G–H). Large black square and circle in each graph represent the mean6 SEM intensity/
diameter coordinates of ipsilateral and contralateral neurons populations, respectively. Scale bar 20 mm. *p,0.05, **p,0.01, ***p,0.001 vs
‘contralateral’, Mann and Whitney rank test.
doi:10.1371/journal.pone.0023083.g005
Nav1.9 Channel Contribution to Inflammatory Pain
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hypersensitivities produced by subacute paw and chronic joint
inflammation. In the subacute inflammatory pain model, these
behavioral observations were correlated with post-transcriptional
modulations of Nav1.9 expression in DRG cell bodies, and with a
strong upregulation of the protein in the peripheral nerve trunks.
Furthermore, at a time where Nav1.9 was strongly overexpressed
in DRG cell bodies, no Nav1.9 current increase could be detected,
suggesting that the newly produced channels are non-functional
and rather intended to be exported to nerve terminals.
The relationship between Nav1.9 and inflammatory pain has
previously been pointed out by different studies, but this is the first
time that one correlates behavioral, molecular and electrophysi-
ological data on the same inflammatory models, with time-course
monitoring. These previous studies also brought out some
discrepancies that needed to be clarified. Firstly, heat hypersen-
sitivity induced by intraplantar carrageenan [15,26] or CFA
[15,16,26] have been reported to be either reduced [15,16] or
unaffected [26] in Nav1.9-null mice. Our results show that Nav1.9
is involved in the decrease in inflammatory heat pain threshold
following carrageenan injection. In the chronic monoarthritis
model, Nav1.9 invalidation also weakened heat hypersensitivity
phenotype, but mostly during the first week of monitoring. Those
results confirm the role of Nav1.9 channel in establishing
inflammatory heat pain hypersensitivity, and to a lower extent,
in its maintenance.
On the other hand, it has previously been shown that Nav1.9
was not involved in inflammatory mechanical hypersensitivity
following intraplantar CFA [15,16,26]. However, this has never
been assessed using a different inflammatory pain model, with the
exception of colorectal distention following colonic TLR7
activation [31]. In this last study, Nav1.9 knock-out mice
presented a reduction of visceral hypersensitivity to mechanical
stimulation. Furthermore, a reduction of mechanical pain
hypersensitivity induced by intraplantar injections of inflammatory
mediators (prostaglandin E2, bradykinin or interleukin-1b) has
been observed in Nav1.92/2 mice [16]. The role played by
Nav1.9 in mechanical hypersensitivity driven by inflammation is
therefore far from clear and further exploration was needed.
Following intraplantar carrageenan injection, our Nav1.92/2
mice exhibited reduced mechanical hypersensitivity compared to
WT littermates. This phenotype, observed with the von Frey test
also used in the previously cited studies [15,16,26], was confirmed
with the use of a new operator-independent dynamic weight
bearing test. Moreover, our data are supported by the reduction of
carrageenan-induced mechanical hypersensitivity observed in
Nav1.9 knock-down rats. Finally, we observed a decrease in
weight imbalance in monoarthritic knock-out mice, showing that
Nav1.9 invalidation is also able to reduce chronic joint pain and
the resultant posture impairment. The negative results previously
Figure 6. Modulation of Nav1.9 protein level in cutaneous sensory fibers innervating the carrageenan-inflamed paw. Co-labeling of
Nav1.9 (A, D) and peripherin (B, E) in small cutaneous nerve trunks in contralateral (A–C) and ipsilateral (D–F) paw skin 24 h after intraplantar
carrageenan injection. Merge images are shown in C and F. Scale bar 28 mm.
doi:10.1371/journal.pone.0023083.g006
Figure 7. Nav1.9 current properties in the carrageenan-
induced paw inflammation model. (A) Time-course of Nav1.9
current up-regulation induced by dialysis of fluoride in the carrageenan
condition. Nav1.9 currents are evoked in a DRG neuron (25 pF) by
50 ms-depolarizing steps from 2100 to 260 mV every 10 s. The inset
shows representative Nav1.9 currents recorded during the time course
of the experiment (as indicated). (B) Mean Nav1.9 current evoked at
260 mV 1 min after patch rupturing and at the peak of the up-
regulation by internal fluoride. The experiments were performed in DRG
neurons from mice injected either with saline (control condition, left
panel) or carrageenan (inflammatory condition, right panel). The
number of cells analyzed is shown on the top of each chart.
doi:10.1371/journal.pone.0023083.g007
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published on mechanical hypersensitivity [15,16,26] may be
inherent to the intraplantar CFA model. Such discrepancies
between inflammatory models have already been reported
between carrageenan and CFA for example, considering either
the efficiency of pharmacological P2X3/P2X2/3 receptors inhibi-
tion [32], or ASIC3 gene deletion [29], on pain hypersensitivity.
Although we could not generalize our conclusions to all the
existing inflammatory pain models, taken together our behavioral
data give numerous and strong evidences that Nav1.9 participates
in lowering heat as well as mechanical pain thresholds during
inflammatory states.
In the second part of this study, we assessed Nav1.9 expression
in both carrageenan and monoarthritis pain models, as many
different studies have reported increased, decreased or stable
Nav1.9 mRNA and/or protein expression following peripheral
inflammation [5,28,33,16,27,29]. Those fragmented information
were furthermore rarely correlated with behavioral data, which is
an issue for the functional interpretation of possible expression
variations. We therefore performed a time-course study of Nav1.9
expression allowing a correlation with the phenotype observed in
animal.
A transient decrease in Nav1.9 protein level was observed in the
soma of DRG neurons 8 h following intraplantar carrageenan,
Figure 8. Pain assessment in Nav1.9 knock-out mice following monoarthritis induction. Heat and mechanical pain sensitivity was
assessed in Nav1.9+/+ and Nav1.92/2 mice (n = 8) over 21 days following monoarthritis induction using 46uC paw immersion test up to the ankle (A)
and dynamic weight bearing (B–E). Animals were injected in the left ankle. The ipsi/contralateral hindpaw weight ratio is shown in C and the
ipsilateral paw lifting time in D. The mean weights applied on ipsilateral and contralateral forepaws are also shown in E and F, respectively. *p,0.05,
**p,0.01, ***p,0.001 vs ‘+/+’, two way ANOVA followed by Student-Newman-Keuls all pairwise multiple comparison test.
doi:10.1371/journal.pone.0023083.g008
Figure 9. Nav1.9 and IL-6 mRNA expression in mouse lumbar
DRGs following monoarthritis induction. Quantitative PCR per-
formed on Nav1.9 (A) and IL-6 (B) transcripts in L4 to L6 ipsilateral DRGs
of mice following monoarthritis induction (n = 3). Results are given
normalized to HPRT transcript levels. *p,0.05, ***p,0.001 vs ‘0’, one-
way ANOVA followed by Bonferroni multiple comparisons versus
control group.
doi:10.1371/journal.pone.0023083.g009
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whereas upregulation was seen 16–24 h post-injection. These
changes in somatal protein level were paralleled with an increase
in cutaneous nerve trunks within the inflamed zone 24 h following
carrageenan injection. These observations strongly suggest that
upon inflammation Nav1.9 protein is exported to the periphery,
depleting the cytoplasmic pool of channels present in the cell body
of sensory neurons, before an increase in its neosynthesis. No such
variation was observed in the monoarthritis model, suggesting
either that the observed mechanism takes place during the
subacute phase of inflammation only, or that a balance between
Nav1.9 production and axonal transport has been reached within
the chronic phase. As no change in Nav1.9 current properties was
detected in DRG neurons innervating the inflamed paw at a time
where Nav1.9 was shown to be upregulated, one can assume that a
non-functional pool of channels is kept at the soma level and
contributes to the increase in their axonal transport. It has been
previously demonstrated that when an inflammatory soup is
applied on cultured sensory neurons, the cells present a
hyperexcitable behavior involving a strong upregulation of
Nav1.9 current [21]. Therefore, we hypothesize that the increase
in peripherally located channels may contribute to fibers’
excitability directly at the site of inflammation.
Nav1.9 modulation by inflammation could temporally be
divided in two steps. First, we propose that a rapid modulation
of Nav1.9 channels takes place in axon terminals. This idea is
supported by the fact that Nav1.9 is present in nerve endings in
physiological conditions [34] and by the fact that in the formalin
test Nav1.9 is involved in spontaneous painful behavior as soon as
10 to 15 min post-injection. Nav1.9 was also shown to be involved
in mechanical hypersensitivity induced by intraplantar PGE2
within 15 min [16], and previous electrophysiological studies have
revealed rapid modulation of Nav1.9 current following GPCR
activation, possibly via a PKC dependent pathway [22,23,24,25].
Secondly, an increase in axonal transport, followed by an
upregulation of Nav1.9 channel expression in cell bodies, might
take place within the first hours of inflammation as to sustain the
excitability of nociceptive terminals.
Changes in Nav1.9 protein expression were not subsequent to
modulations in mRNA level, as Nav1.9 transcript remained stable
at all time-points tested. Post-transcriptional regulation of VGSCs
has been reported previously. For example, Nav1.8 protein but not
the corresponding mRNA has been shown to be upregulated in
DRG neurons following colonic inflammation [35]. The non-
selective cation channel TRPV1 has also been shown to be
massively and unilaterally exported to the periphery 24 h
following intraplantar CFA [36], sustained by a post-transcrip-
tional upregulation of the channel expression in DRG cell bodies.
This type of regulation may occur at different levels, such as
dysregulation of mRNA stability, as shown for the Nav1.7 channel
[37], or modulation of its translation by RNA binding proteins, as
for the ENaC channel [38].
Regarding to these results, Nav1.9 channel may potentially be a
suitable pharmacological target for inflammatory pain care.
Complete loss of function, as well as partial silencing, were both
able to reduce inflammatory pain hypersensitivity, not depending
on the nature of the noxious stimuli, while those treatments had no
effect on pain thresholds in healthy animal. Thus, drugs inhibiting
Nav1.9 should be considered as potential anti-hyperalgesics rather
than analgesics, which is conceptually innovative.
Materials and Methods
Animals
All animals were used in accordance with the European
Community guiding in the care and use of animals (86/609/
CEE). Since pain might result from these experiments, the
guidelines of the Committee for Research and Ethical Issue of
the International Association for the Study of Pain [39] were
followed. Furthermore, the models used in this study were all
approved by the ethics committee of Auvergne (Comite´ Re´gional
d’Ethique en Matie`re d’Expe´rimentation Animale Auvergne;
approvals CE13-10, CE09-08 and CE07-08). Great care was
taken, particularly to housing conditions, to avoid or minimize
discomfort of the animals. Animals were housed under controlled
environmental conditions and kept under a 12/12 h light/dark
cycle, with food and water ad libitum.
Nav1.9 knock-out mice were generated from C57Bl6/J strain as
previously described [21]. Briefly, an IRES LacZ-pA cassette
starting by a stop codon was inserted between exons 5 and 8 of the
Scn11a gene, resulting in a depletion of exons 6 and 7 and the
production of a non-functional, truncated protein. Behavioral
experiments were performed blind to genotype on Nav1.9+/+ and
Figure 10. Nav1.9 current properties in the monoarthritis ankle inflammation model. (A) Time-course of Nav1.9 current up-regulation
induced by dialysis of fluoride in the monoarthritis condition. Nav1.9 currents are evoked in a DRG neuron (38 pF) by 50 ms-depolarizing steps from
2100 to 260 mV every 10 s. The inset shows representative Nav1.9 currents recorded during the time course of the experiment (as indicated). (B)
Mean Nav1.9 current evoked at 260 mV 1 min after patch rupturing and at the peak of the up-regulation by internal fluoride. The experiments were
performed in DRG neurons from control (injected with saline, left panel) or monoarthritic mice (right panel). The number of cells analyzed is shown
on the top of each chart.
doi:10.1371/journal.pone.0023083.g010
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Nav1.92/2 littermates (8–14 weeks) isolated after genotyping on
hair samples. Non behavioral experiments were performed on 20–
24 g C57Bl6/J mice (Charles River).
Antisense studies were performed on 150–175 g Sprague
Dawley rats (Charles River). Prior to experiments, animals
received 6 intrathecal injections every 12 h of saline, 12.5 mg
mismatch (59-GCCTTGTCTTTGGACTTCTTC-39) or anti-
sense oligodeoxynucleotides to Nav1.9 (59-GCTCTGTTCTT-
GAGCTTTCTC-39) in 10 ml saline [12].
Inflammatory models
Subacute paw inflammation was induced by intraplantar
injection of 20 and 50 ml of 3% l-carrageenan (Sigma) in mice
and rats, respectively. Chronic inflammation (monoarthritis
model) was induced under 2% isoflurane anesthesia by two
subcutaneous injections of 15 ml around the tibio-tarsal joint of
mice with complete Freund adjuvant (CFA), containing 5 mg/ml
heat-killed Mycobacterium tuberculosis (Becton, Dickinson and cie)
[40]. Indomethacin (Sigma) was injected intraperitonealy at a
1 mg/kg dose from a 0.3 mg/ml suspension in 0.5% methylcel-
lulose.
Behavioral assays
Formalin test. Mice were administered 15 ml of 5% formalin
in saline subcutaneously in the left hindpaw. The time spent liking
or biting the injected paw was monitored during the two typical
phases of nociceptive behavior (0–5 min and 10–45 min post-
injection).
Von Frey test. Mechanical pain threshold was assessed using
von Frey filaments (BioSeb) calibrated from 0.008 to 4.000 g. The
filaments were applied 5 times each, in order of increasing forces,
and pressed perpendicularly to the plantar surface of the hindpaw
until they bent. The first filament which evoked at least 3 responses
was assigned as the pain threshold in grams.
Dynamic weight bearing. The animals’ weight distribution
on the four limbs was assessed using the dynamic weight bearing
test (BioSeb). This new incapacitance test consists in a continuous
measurement of all pressure points applied by a freely moving
animal, allowing a quantitative evaluation of the weight imbalance
caused by paw mechanical allodynia. Mice were placed in an
11611622 cm cage with a 44644 sensor cells grid on the floor.
The pressure applied on sensor cells by the animal’s paws is
recorded at a 10 Hz frequency over a 5 min period. Pressure and
surface detection thresholds were determined automatically for
each animal by the Dynamic weight bearing 1.3.2h software
(Bioseb). After the manual attribution of each pressure point to the
corresponding paw, the mean weight applied on each paw is
calculated. Unilateral pain is finally evaluated trough the ipsi/
contralateral hindpaws weight ratio, the weight applied on
forepaws, and the percentage of time spent raising ipsilateral
hindpaw.
Paw pressure test. The rats were submitted to the paw-
pressure test previously described by Randall and Selitto [41].
Nociceptive thresholds, expressed in grams, were measured using
an Ugo Basil analgesimeter (probe tip diameter 1 mm, Bioseb) by
applying an increasing pressure to the hindpaw until vocalisation
was elicited. The maximal pressure was set at 450 g.
Paw immersion test
To assess heat pain threshold, mice and rats were gently held
and the hindpaw was immersed in a 46uC water bath until
withdrawal was observed. The first two consecutive stable
withdrawal latencies were averaged out and assigned as the pain
threshold in seconds. A cutoff time of 15 s was applied to avoid
injury.
Nav1.9 expression analysis
Real-time PCR. Mice were sacrificed by decapitation under
isoflurane anesthesia. Ipsilateral and contralateral DRGs from
lumbar segments L4 to L6 were rapidly dissected in 4uC
phosphate buffer saline (PBS) and stored at 280uC for
subsequent RNA extraction. To ensure sufficient RNA quantity,
each assessed sample is the result of a 5 animal DRGs pool. RNA
was isolated using RNeasy mini kit (Qiagen) according to the
manufacturer instructions, including a 15 min DNase incubation
step. Purified RNA was quantified by measuring the 260 nm
absorbance (A260) on a V-550 spectrophotometer (Jasco) and
quality was assessed by analyzing the A260/A280 and A260/A230
ratios. Integrity of RNA samples was confirmed by electrophoresis
on a 1.5% agarose gel. Before quantitative PCR analysis, 1 mg of
total RNA was submitted to reverse transcription with SuperScript
II Reverse Transcriptase (Invitrogen) in a 20 ml volume, using the
supplier’s procedure. PCR amplifications were performed using a
Mastercycler ep realplex (Eppendorf). All samples were run in
triplicate in a final volume of 6.3 ml containing 1.3 ml of 1/40
diluted cDNA, 0.5 mM primers, 3 mM MgCl2 and LightCycler
Fast-Start SYBR Green reaction mix (Roche), according to
manufacturer protocol. Prior to PCR, an 8 min enzyme
activation step was done at 95uC. The PCR protocol consisted
of 10 s denaturation at 95uC, 5 s at annealing temperature and
10 s elongation at 72uC for 40 cycles. Optimal annealing
temperature was preliminary determined by gradient PCR. The
primers sequences used were the following, from 59 to 39:
TTCCACTCTACGTACCTTCCGAGT (forward) and ATTC-
CCATGAAGAGCTGCTGACCA (reverse) for Nav1.9 (NM_
011887, 180 bp); ATGGATGCTACCAAACTGGAT (forward)
and TGAAGGACTCTGGCTTTGTCT (reverse) for IL-6 (NM_
031168, 139 bp); TTGCTGACCTGCTGGATTAC (forward)
and AGTTGAGAGATCATCTCCAC (reverse) for HPRT
(NM_013556, 149 bp). Amplification specificity was assessed by
melting curve analysis and PCR products were run on a 3%
agarose gel to confirm amplicons sizes. Primers were designed on
intron-flanking sequences to prevent genomic contamination.
Nav1.9 and HPRT cDNA relative amounts were calculated
function of the samples cycle threshold (Ct) using a standard
concentration curve constructed with a serial dilution from 1/10
to 1/640 of a total cDNA mix. For each sample, the relative
amount of Nav1.9 cDNA was normalized by the HPRT cDNA
amount.
Immunohistochemistry. Beforehand dissection, animals
were assessed for mechanical hypersensitivity using von Frey test
as described above. DRG and skin samples were quickly removed
from freshly killed animals and incubated for 1 h in PBS
containing 4% sucrose, and then incubated for at least one hour
in PBS plus 15% sucrose. Tissues were then embedded in Tissue-
TEK OCT compound (Miles Inc.) and frozen in 260uC dry-ice
cooled isopentane. 14 mm thick serial sections were performed
with a HM500M Microm cryostat and set down on Superfrost
Plus slides. Unspecific binding was reduced by pre-incubating
samples in blocking buffer consisting of 3% Bovine Serum
Albumin (BSA) and 0.1% triton X-100 in PBS for 1 h. Primary
antibodies were incubated in blocking buffer without triton X-100
overnight at 4uC. After several washes in PBS, secondary
antibodies were incubated in PBS containing 3% BSA for 1 h at
room temperature. After several washed in PBS, sections were
mounted in Mowiol. Antibody dilutions were: anti-Nav1.9 L23, 1/
400 [34] ; anti-peripherin, 1/400 (Chemicon). Goat anti-rabbit
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IgG Alexa Fluor 488 (1/400, Molecular Probes) and goat anti-
mouse IgG Alexa Fluor 546 (1/400, Molecular Probes) were used
as secondary antibodies. Optical conventional fluorescence
microscopy was performed on an Olympus microscope equipped
with CellR acquisition software (Olympus). Structured
illumination microscopy, for skin images, was performed on the
ApoTome system (Zeiss). Image editing was performed using
Adobe Photoshop (Adobe Systems).
Flurorescence quantification. Nav1.9 fluorescence signal
was quantified with cellR software (Olympus). For each animal,
immunostaining of ispi and contralateral DRG sections were
performed simultaneously with the same batch of antibody.
Pictures were recorded with the same acquisition parameters,
paying attention to avoid any saturation of the signal. Pictures
were taken as 8 bit images with 256 (from 0 to 255) possible grey
levels. Around a hundred neurons were analysed for each contra
and ipsilateral DRG. Mean grey value was measured on a 5.3 mm
diameter ROI (Region Of Interest). For each image, mean
background was also measured with three ROI, and subtracted to
the Nav1.9 fluorescence signal.
Electrophysiology
Acutely dissociated DRG cells. DRG neurons innervating
skin from young male mice were labeled by the fluorescent dye DiI (5
repetitive subcutaneous injections of 1 ml in 5% DMSO, Molecular
Probes). Dye was injected 3 days before injection of saline,
carrageenan, or CFA, depending of the considered model.
Beforehand dissection, mechanical hypersensitivity was assessed as
described above. In the carrageenan and monoarthritis models, mice
were sacrificed respectively 20 h and 7 days after the induction of the
inflammation. Dissociation of DRG neurons was performed as been
previously described [42,21]. Briefly, lumbar ipsilateral L4 to L6DRGs
were dissected and incubated in Hank’s balanced salt solution (HBSS,
Invitrogen) containing collagenase IA (2 mg/ml, Sigma) for 45 min at
37uC. DRGs were then triturated using a fired polished Pasteur pipette
in HBSS medium and cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) supplemented with heat-inactivated
fetal calf serum (10%), penicillin-streptomycin (100 units/ml), L-
glutamine (2 mM), Nerve Growth Factor (25 ng/ml, Gibco) and Glial
Derived Neurotrophic Factor (2 ng/ml, Gibco). Cells were maintained
in a humidified atmosphere (5% CO2, 37uC) for 3–6 h before
recording.
Patch clamp recordings. Whole-cell voltage clamp
recordings were made at room temperature (20–24uC) using an
Axopatch 200B amplifier (Axon Instruments), filtered at 2 kHz
and digitally sampled at 20–50 kHz using PCLAMP 8.02
software. Currents were leak subtracted using a P/6 protocol.
Voltage errors were minimized using 70–85% series resistance
compensation. Patch pipettes (1.9–2.5 MV) contained (in mM):
100 CsCl, 30 CsF, 8 NaCl, 1 CaCl2, 1 MgCl2, 10 EGTA, 10
Hepes, 4 MgATP, 0.4 Na2GTP (pH 7.2, 300 mOsm/l). Bath
solution had a reduced driving force for Na+ and contained (in
mM): 60 NaCl, 110 sucrose, 3 KCl, 1 MgCl2, 10 Hepes, 2.5
CaCl2, 10 glucose, 10 TEA-Cl, 0.0005 TTX, 0.005 LaCl3, 1
amiloride (pH 7.4, 305 mOsm/l). All chemicals were obtained
from Sigma except TTX (Alomone Labs). DRG neurons were
perfused with bath solution at a flow rate of 2.5 ml/min.
Data analysis
Raw data were analyzed for statistical significance using either
one-way ANOVA followed by Bonferroni multiple comparisons
versus control group, two-way ANOVA followed by Student-
Newman-Keuls all pairwise multiple comparison procedure,
Student’s unpaired t-test or Mann-Whitney test (SigmaPlot)
depending on the experimental design. For a better understand-
ing, the tests used are indicated in the corresponding figure legend.
All values are shown as mean 6 standard error of the mean
(SEM).
Supporting Information
Figure S1 Carrageenan and monoarthritis-induced oe-
dema monitoring in Nav1.92/2mice. Paw edema induced by
intraplantar carrageenan was measured from 0 to 24 h post-injection
using a micrometer in Nav1.92/2 and Nav1.9+/+ mice (A, n=9).
Ankle swelling following monoarthritis induction was measured from 0
to 21 days post-CFA injection in Nav1.92/2 and Nav1.9+/+ mice (B,
n=8). No significant difference occurred between genotypes in both
models, assessed by two-way ANOVA followed by Student-Newman-
Keuls all pairwise multiple comparison test.
(TIF)
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